Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2024 ∙ Tinessia, A. Clark, K. Randell, M. Leask, J. King, C.
Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review
All age groups COVID-19 Acceptance
Rating:
Not applicable
2024 ∙ Du, P. Jin, S. Lu, S. Wang, L. Ma, X. Wang, J. Huang, R. Luo, Q. Yang, S. Feng, X.
Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: a systematic review and network meta-analysis
Adults Older adults Influenza Pneumococcal disease Coverage
Rating:
Not applicable
2024 ∙ de Koning, R. Gonzalez Utrilla, M. Spanaus, E. Moore, M. Lomazzi, M.
Strategies used to improve vaccine uptake among healthcare providers: A systematic review
Healthcare workers Coverage
Rating:
Not applicable
2024 ∙ Diakite, I. Martins, B. Owusu-Edusei, K. Palmer, C. Patterson-Lomba, O. Gomez-Lievano, A. Zion, A. Simpson, R. Daniels, V. Elbasha, E.
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts
All age groups Human papillomavirus (HPV) Modeling
Rating:
Not applicable
2024 ∙ Riemma, G. Etrusco, A. Laganà, A. S. Torella, M. Vastarella, M. G. Della Corte, L. D'Amato, A. La Verde, M. De Franciscis, P. Cobellis, L.
Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence
Adults COVID-19 Safety
Rating:
Low
2024 ∙ Wong, B. K. Mabbott, N. A.
Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
Adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Marra, F. Yip, M. Cragg, J. J. Vadlamudi, N. K.
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations
Adults Older adults Herpes zoster Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Levin, A. Yeung, K. H. T. Hutubessy, R.
Systematic review of cost projections of new vaccine introduction
All age groups Economic aspects
Rating:
Not applicable
2024 ∙ Moradiya, P. Khandelwal, P. Raina, R. Mahajan, R. G.
Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Williams, S. V. Akande, T. Abbas, K.
Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria
Africa Nigeria Newborn Children Low and Middle Income Countries Coverage
Rating:
Not applicable
Loading...